Daniel DiRenzo (Daniel Direnzo)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Atrial Fibrillation

Hematopoietic Stem Cell

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Molecular cancer therapeutics

Stanford University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Stanford University Aug 01 2014 - Nov 01 2016

United States

Postdoctoral fellow :: Vascular Surgery

Publications

Dana Piovesan, Joanne B L Tan, Annette Becker, Jesus Banuelos, Nell N Narasappa, Daniel DiRenzo, Kristen Zhang, Ada Chen, Elaine Ginn, Akshata R Udyavar, Fangfang Yin, Susan L Paprcka, Bhamini Purandare, Timothy W Park, Nikki Kimura, Jaroslaw Kalisiak, Stephen W Young, Jay P Powers, Uli Schindler, Kelsey E Sivick, Matthew J Walters
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity. Molecular cancer therapeutics 21 (6) (2022)
Ying Wang, Vivek Nanda, Daniel DiRenzo, Jianqin Ye, Sophia Ying Xiao, Yoko Kojima, Kathryn L Howe, Kai-Uwe Jarr, Alyssa M Flores, Pavlos Tsantilas, Noah Tsao, Abhiram Rao, Alexandra A C Newman, Anne Verena Eberhard, James R Priest, Arno Ruusalepp, Gerard Pasterkamp, Lars Maegdefessel, Clint L Miller, Lars Lind, Simon Koplev, Johan L M Björkegren, Gary K Owens, Erik Ingelsson, Irving L Weissman, Nicholas J Leeper
Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade. Proceedings of the National Academy of Sciences of the United States of America 117 (27) (2020)